The CPAP Mask Feature with Greatest Positive Impact
A recent survey reveals what sleep techs, RTs, and lab managers value most in positive airway pressure interfaces.
Category: Sleep Treatments
Sleep Treatments
Latest
Sleep Treatments
Latest
Acquisition Marks New Phase for Advanced Brain Monitoring
ABM was acquired by Cadence Health Capital last month. A new leadership team at the neurology-forward sleep company plans to streamline operations and expand the clinical reach of validated technologies for sleep apnea, insomnia, and neurodegenerative disease.
Sleep Treatments
Latest
Surprising Duration of Self-Maintained Positional Therapy Benefits Offers New OSA Strategy
Research presented at ATS 2026 reveals that positional therapy conditions patients to avoid back-sleeping, maintaining obstructive sleep apnea control for up to a year after device withdrawal.
CPAP & PAP Devices
Latest
How to Afford CPAP + GLP-1 Polytherapy
What can sleep physicians do when obstructive sleep apnea patients can't afford every recommended therapy?
Insomnia Devices
Latest
Nexalin Acquires Digital Health Platform Ahead of FDA Pivotal Trial for Insomnia Treatment
The acquisition of PONM gives Nexalin ownership of the AI-integrated software supporting its HALO Clarity program, preparing for a 160-participant trial for moderate-to-severe insomnia.
Therapy Devices
Latest
Nyxoah Initiates Search for US-Based CEO to Accelerate Genio Launch
The medical technology company is transitioning leadership to focus on its next phase of growth and commercial traction for its obstructive sleep apnea therapy in the US market.
Pharmaceuticals
Latest
Drug Used Off-Label for Insomnia Improves Sleep But Impairs Next-Day Alertness in OSA Patients
Flinders University researchers have led a clinical trial examining how a commonly prescribed ‘sleeping pill’ affects sleep, breathing, and next‑day performance.
Surgeries & Procedures
Latest
Which Costs Less: GLP-1s or Bariatric Surgery?
A retrospective study explores how surgical and pharmacologic weight-loss strategies stack up in cost, effectiveness, and health outcomes.
Behavioral Sleep Medicine
Latest
New DARC-NESS Model Explains Why Nightmares Persist in Children
A mastery-based cognitive-behavioral model centers on "nightmare efficacy" to help clinicians create personalized treatment plans for youth.